Application of Medical Imaging Procedures in Surgery Implanting in Cancerology With the Aim to Reduce Invasive Acts (ATIM)

June 21, 2011 updated by: Centre Leon Berard
Aero digestive Cancer patients treated by external head and neck radiotherapy and/or by curie-therapy and/or mandible reconstruction by microanastomosed fibula flaps. The purpose of the study is to Investigate the accuracy of implants insertion in the anteroposterior way, using radiosurgical guidance.

Study Overview

Detailed Description

  • Investigate the accuracy of inserting implants in the vertical way and in angulation, on irradiated native mandible or on microanastomosed fibula flaps
  • Investigate the accuracy of inserting implants in the anteroposterior way, in the vertical way and in angulation for all the involved patients (meaning on irradiated native mandible or on microanastomosed fibula flaps)
  • Investigate the delay of mucous healing
  • Estimate the prosthetic function
  • Evaluate the osteonecrosis rate after radiation with traumatic etiology due to implantation
  • Estimate the implant rate due to minimally invasive flaps
  • Estimate the implant rate due to pure trans mucosa way
  • Estimate the post surgical therapeutic success after 1 year

Study Type

Interventional

Enrollment (Anticipated)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-ferrand, France, 63 000
        • CHU Hôtel-Dieu Service d'Odontologie
      • Lyon, France, 69007
        • Hospices Civils de Lyon Service de Consultations et Traitements Dentaires
      • Pierre Benite, France, 69495
        • Centre Hospitalier Lyon Sud Service de Stomatologie et Chirurgie Maxillo-Faciale
    • Cedex 08
      • Lyon, Cedex 08, France, 69373
        • Centre Léon Bérard Service de Chirurgie-Stomatologie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age over 18
  • Performance status over 70
  • Histological evidence of upper digestive tract cancer
  • History of cranial / facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
  • Bone volume sufficient to support an implant.
  • Mandatory affiliation with a social security system
  • Written, voluntary, informed consent

Exclusion Criteria:

  • Patient with evolutive malignant disease
  • Contraindication to general anesthesia
  • Concurrent disease contra-indicating implant surgery (risk of infectious endocarditis, uncontrolled diabetes, HIV, evolutive neoplasia…)
  • Patient enrolled in another clinical trial including chemotherapy
  • Pregnant or lactating woman
  • Anticipation of an impossible follow-up
  • Patient deprived of freedom

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Accuracy of implants insertion, radio-surgical guidance.
Time Frame: 8 months after inclusion
8 months after inclusion

Secondary Outcome Measures

Outcome Measure
Time Frame
Accuracy of inserting implants
Time Frame: 16 months after inclusion
16 months after inclusion
Delay of mucous healing
Time Frame: 16 months after inclusion
16 months after inclusion
Estimation of the prosthetic function
Time Frame: 16 months after inclusion
16 months after inclusion
Osteonecrosis rate after radiation with traumatic etiology due to implantation
Time Frame: 16 months after inclusion
16 months after inclusion
Implant rate
Time Frame: 16 months after inclusion
16 months after inclusion
Post surgical therapeutic success after 1 year
Time Frame: after 1 year
after 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne-Gaëlle BODARD, MD, Centre Léon Bérard

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2007

Primary Completion (Anticipated)

December 1, 2011

Study Completion (Anticipated)

December 1, 2011

Study Registration Dates

First Submitted

June 2, 2009

First Submitted That Met QC Criteria

June 19, 2009

First Posted (Estimate)

June 22, 2009

Study Record Updates

Last Update Posted (Estimate)

June 22, 2011

Last Update Submitted That Met QC Criteria

June 21, 2011

Last Verified

June 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Digestive Tract Cancer

Clinical Trials on Therapeutic assessment -Radio-surgical guidance.

Subscribe